Cytokines News and Research

Latest Cytokines News and Research

Imaging microscopy shows killer T-cells targeting SARS-CoV-2 spike protein

Imaging microscopy shows killer T-cells targeting SARS-CoV-2 spike protein

30 Jan 2022
Damon Runyon Cancer Research Foundation announces newest cohort of Fellows and Breakthrough Scientists

Damon Runyon Cancer Research Foundation announces newest cohort of Fellows and Breakthrough Scientists

29 Jan 2022
A synthesis of evidence sheds light on major immune components and mechanisms involved in COVID-19

A synthesis of evidence sheds light on major immune components and mechanisms involved in COVID-19

28 Jan 2022
γ’ fibrinogen as a disease progression marker for COVID-19

γ’ fibrinogen as a disease progression marker for COVID-19

28 Jan 2022
Study demonstrates minimally invasive, aerosolized vaccine candidate to combat SARS-CoV-2

Study demonstrates minimally invasive, aerosolized vaccine candidate to combat SARS-CoV-2

28 Jan 2022
Intranasal interferon-λ treatment protects mice against SARS-CoV-2 Beta and Omicron variants

Intranasal interferon-λ treatment protects mice against SARS-CoV-2 Beta and Omicron variants

28 Jan 2022
Early-stage alveolar epithelial cell necrosis linked to COVID-19-induced acute respiratory distress syndrome

Early-stage alveolar epithelial cell necrosis linked to COVID-19-induced acute respiratory distress syndrome

27 Jan 2022
Risk of long COVID-19 predicted by immunoglobulin signature

Risk of long COVID-19 predicted by immunoglobulin signature

27 Jan 2022
T-cell apoptosis linked to poor prognosis among COVID-19 patients

T-cell apoptosis linked to poor prognosis among COVID-19 patients

26 Jan 2022
Study shows enduring T-cell immunity up to at least 1-year after SARS-CoV-2 infection

Study shows enduring T-cell immunity up to at least 1-year after SARS-CoV-2 infection

26 Jan 2022
Alterations of sphingolipids and their metabolizing enzymes in hospitalized or convalescent COVID-19 patients

Alterations of sphingolipids and their metabolizing enzymes in hospitalized or convalescent COVID-19 patients

26 Jan 2022
SARS-CoV-2 Omicron variant found to display increased resilience to antiviral type I interferon response

SARS-CoV-2 Omicron variant found to display increased resilience to antiviral type I interferon response

26 Jan 2022
Understanding immune responses to SARS-CoV-2 infections in children

Understanding immune responses to SARS-CoV-2 infections in children

26 Jan 2022
Cannabidiol inhibits SARS-CoV-2 replication in human cells and mice

Cannabidiol inhibits SARS-CoV-2 replication in human cells and mice

26 Jan 2022
SARS-CoV-2 virus co-opts intrinsic cellular machinery to suppress interferon production

SARS-CoV-2 virus co-opts intrinsic cellular machinery to suppress interferon production

25 Jan 2022
Spike-mediated CFTR inhibition accounts for airway inflammation in COVID-19

Spike-mediated CFTR inhibition accounts for airway inflammation in COVID-19

25 Jan 2022
Characterization of unique pathogenesis of SARS-CoV-2 Delta variant in mouse model

Characterization of unique pathogenesis of SARS-CoV-2 Delta variant in mouse model

24 Jan 2022
Genetic marker linked to higher risk of death in COVID-19 patients

Genetic marker linked to higher risk of death in COVID-19 patients

23 Jan 2022
Echinacea as a potential force against coronavirus infections

Echinacea as a potential force against coronavirus infections

21 Jan 2022
Development of a glycoprotein multi-epitope subunit vaccine candidate against South-African SARS-CoV-2 strains

Development of a glycoprotein multi-epitope subunit vaccine candidate against South-African SARS-CoV-2 strains

20 Jan 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback